首页> 美国卫生研究院文献>PLoS Clinical Trials >Noninvasive Prenatal Diagnosis of Fetal Trisomy 21 by Allelic Ratio Analysis Using Targeted Massively Parallel Sequencing of Maternal Plasma DNA
【2h】

Noninvasive Prenatal Diagnosis of Fetal Trisomy 21 by Allelic Ratio Analysis Using Targeted Massively Parallel Sequencing of Maternal Plasma DNA

机译:母体血浆DNA靶向大规模并行测序的等位基因比率分析对胎儿三体性21的无创产前诊断。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPlasma DNA obtained from a pregnant woman contains a mixture of maternal and fetal DNA. The fetal DNA proportion in maternal plasma is relatively consistent as determined using polymorphic genetic markers across different chromosomes in euploid pregnancies. For aneuploid pregnancies, the observed fetal DNA proportion measured using polymorphic genetic markers for the aneuploid chromosome would be perturbed. In this study, we investigated the feasibility of analyzing single nucleotide polymorphisms using targeted massively parallel sequencing to detect such perturbations in mothers carrying trisomy 21 fetuses.
机译:背景从孕妇获得的血浆DNA包含母体和胎儿DNA的混合物。根据整倍体妊娠中不同染色体上的多态性遗传标记确定,母体血浆中胎儿DNA的比例相对一致。对于非整倍体妊娠,使用非整倍体染色体的多态遗传标记测量的观察到的胎儿DNA比例会受到干扰。在这项研究中,我们调查了使用靶向大规模平行测序分析单核苷酸多态性以检测携带21三体胎儿的母亲的摄动的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号